AtaiBeckley Inc. CEO Dr Srinivas Rao joined Steve Darling from Proactive to discuss topline results from the company’s exploratory, double-blind, placebo-controlled Phase 2a trial evaluating EMP-01 in ...
EMP-01 met its primary objective on safety and tolerability, demonstrating a generally favorable and manageable safety and tolerability ...
April 3, 2025: North Korea has tested a missile launched ElectroMagnetic Pulse or EMP weapon. This took place on April 29th as the conventional missile warhead detonated at 72 kilometers altitude.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results